SCHEMBL6022926

SCHEMBL6022926

CC(C)(C)c1cc(C(=O)C=CN2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc(C(C)(C)C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.47
CTSB P07858 1/20 0.47
SIRT6 Q8N6T7 1/20 0.47
ALDH1A1 P00352 5/20 0.47
MAPT P10636 3/20 0.47
LMNA P02545 2/20 0.47
TNFRSF1A P19438 1/20 0.45
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
HTT P42858 3/20 0.44
MEN1 O00255 1/20 0.44
GALR3 O60755 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
AKR1C3 P42330 1/20 0.44
POLB P06746 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
HSD11B1 P28845 1/20 0.43
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023217 0.85 TNFRSF1A (0.48) ALDH1A1MAPTLMNATNFRSF1AGAA
SCHEMBL4310719 0.81 CRHBP (0.60) SIRT6ALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL6022671 0.79 MAPT (0.46) CTSLCTSBALDH1A1MAPTLMNA
SCHEMBL6022682 0.79 MAPT (0.45) CTSLCTSBALDH1A1MAPTLMNA
SCHEMBL6022932 0.77 MAPT (0.57) CTSLCTSBSIRT6ALDH1A1MAPT
SCHEMBL4318947 0.75 POLB (0.58) SIRT6ALDH1A1MAPTLMNAGAA
SCHEMBL4309961 0.74 POLB (0.65) ALDH1A1MAPTLMNASMN1; SMN2HTT
SCHEMBL4379029 0.72 TNFRSF1A (0.48) ALDH1A1MAPTLMNATNFRSF1AGAA
SCHEMBL11529933 0.70 L3MBTL1 (0.63) ALDH1A1MAPTLMNAGAASMN1; SMN2
SCHEMBL4322184 0.69 KMT2A (0.57) ALDH1A1MAPTLMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 CTSL 3001/4885CTSB 1130/4885SIRT6 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.